Laboratorios Farmaceuticos Rovi (ES:ROVI) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Laboratorios Farmacéuticos Rovi, S.A. has reported its operations on own shares for the second quarter of 2024, indicating active trading under its liquidity contract with Bestinver SV, S.A. The company concluded the quarter with a final balance of 92,369 shares and a cash account balance of nearly 6 million euros, reflecting a dynamic market performance.
For further insights into ES:ROVI stock, check out TipRanks’ Stock Analysis page.